威尼托克拉克斯对急性骨髓性白血病的疗效通过与丁酸盐的结合而增强
Renshi Kawakatsu1, Kenjiro Tadagaki1, Kenta Yamasaki1
1Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
乙酸盐 (NaB) 增强了venetoclax在急性髓性白血病 (AML) 细胞中的疗效. 这种组合疗法显著促进细胞死亡,为AML治疗提供了一个有前途的新策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 作为Bcl-2抑制剂的Venetoclax已被批准用于治疗急性髓性白血病 (AML).
- 威尼托克拉克斯的疗效有限,需要新的治疗策略.
- 像venetoclax这样的BH3-模仿剂通过抑制抗亡蛋白质来诱导亡.
研究的目的:
- 为了研究甲酸盐 (NaB) 的潜力,以提高venetoclax在AML中的疗效.
- 探索结合NAB与venetoclax对AML细胞死亡的协同效应.
- 阐明联合治疗效果背后的机制.
主要方法:
- 用NaB和/或venetoclax治疗AML细胞系 (KG-1,SKNO-1) 和慢性髓性白血病 (CML) 细胞系 (K562).
- 细胞死亡诱导和细胞亡的评估.
- 分析亲细胞亡因素 (Bax,Bak) 和酶基质裂解 (PARP).
主要成果:
- 单剂NaB或venetoclax在KG-1细胞中显示出弱细胞死亡诱导.
- 与NAB和venetoclax的联合治疗大大诱导了AML细胞系中的细胞死亡.
- NaB上调了Bax和Bak,增强了venetoclax诱导的亡,这是PARP裂变所证明的.
- 该组合专门针对AML细胞,省略K562细胞,表明AML的特异性.
结论:
- 酸盐协同增强了急性髓性白血病细胞中venetoclax诱导的亡.
- 组合疗法代表了一种新的和特定的策略,以改善venetoclax治疗AML的治疗结果.
- 促亡因子Bax和Bak的上调有助于协同效应.
更多相关视频
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs for Treatment of Constipation-Predominant IBS
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
